Back to today’s briefing

Story perspectives

85% Support Pharmacogenomics Testing, But Awareness Lags

3/12/2025

38 7

Summary

Story summary

A recent survey from Queen Mary University of London reveals that a striking 85% of UK adults back pharmacogenomics (PGx) testing for patients with multiple health issues. However, a staggering 93% remain unaware of PGx, raising alarms about the need for better public education and addressing concerns over data sharing and informed consent.

1 of 1

Story summary

A recent survey from Queen Mary University of London reveals that a striking 85% of UK adults back pharmacogenomics (PGx) testing for patients with multiple health issues. However, a staggering 93% remain unaware of PGx, raising alarms about the need for better public education and addressing concerns over data sharing and informed consent.